Wells Fargo produced the most ambiguous result of Tuesday’s concentrated bank earnings session, beating the consensus earnings per share estimate of $1.58 with reported diluted EPS of $1.60 while simultaneously missing on net interest income in a way that investors refused to overlook.
The stock fell approximately 4.8 percent through the trading session, making it the worst performer among its large-bank peers on a day when the sector broadly moved higher.
The core issue was net interest income of $12.1 billion, which fell short of the $12.3 billion analyst consensus despite the bank’s loan book surpassing the $1 trillion mark for the first time since early 2020 and growing 11 percent year on year.
The disconnect between volume growth and yield performance reflected the “deposit beta” problem, the necessity of paying higher interest rates to retain depositors who would otherwise move cash into money market funds, which compressed margins in a way that offset the volume benefit.
CEO Charlie Scharf framed the quarter positively in his official statement, citing the EPS growth of 15 percent, revenue growth of 6 percent, and the continued progress on operational efficiency. Wells Fargo returned $4 billion to shareholders through share repurchases. The CET1 capital ratio stood at 10.3 percent. Credit quality was sound, with net loan charge-offs of 0.45 percent of average loans remaining stable.
The Federal Reserve asset cap, which has constrained Wells Fargo’s balance sheet growth for years, remains the structural overhang that most significantly differentiates the bank from its peers. Investors had been waiting for signs that the cap might be lifted, and Tuesday’s results provided no news on that front. The market is now asking a harder question: what does Wells Fargo do with the cap once it is finally removed?
The answer, based on this quarter, involves significantly expanding the loan book and competing more aggressively for deposits. The infrastructure for that expansion is being built. The financial performance to demonstrate its potential has not yet arrived at the scale that would command the premium valuation that full recovery would justify.
